Shuaiying Cui, Ph.D.1*, Jose Sangerman, Ph.D.2*, Seyed Mehdi Nouraie, M.D., Ph.D.3*, Yan Dai, Ph.D.4*, Oluwakemi Owoyemi, M.D, MPH5*, Robert E. Taylor, MD, PhD6 and Susan P. Perrine, M.D.7
1Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI
2Cancer Center, Hemoglobinopathy Thalasssemia Research Unit, Boston University School of Medicine, Boston, MA
3Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, D.C.
4Cancer Center, Boston University School of Medicine, Boston, MA
5Center for Sickle Cell Disease, Howard University, Washington, DC
6Department of Medicine, Howard University, Washington, DC
7Cancer Center, Hemoglobinopathy Thalassemia Research Unit, Boston Univ. School of Med., Boston, MA